Management of primary cardiac sarcomas

Area of Science:

• Cardiology
• Surgical Oncology
• Medical Oncology

Background:

• Cardiac sarcomas are rare soft-tissue tumors with aggressive behavior.
• Metastatic spread and local recurrence significantly impact patient survival.
• Histologic grade and type influence prognosis, with chemotherapy and radiation offering limited long-term efficacy.

Purpose of the Study:

• To review the clinical behavior, classification, and treatment strategies for cardiac sarcomas.
• To evaluate the role of surgery, including cardiac autotransplantation, in managing these rare tumors.
• To highlight the limitations of current therapies and the need for improved systemic control.

Main Methods:

• Classification of cardiac sarcomas into right heart, left heart, and pulmonary artery types based on surgical approach and behavior.
• Review of treatment modalities including chemotherapy, radiation, and surgical resection.
• Evaluation of surgical techniques like cardiac autotransplantation for specific tumor locations.

Main Results:

• Right heart sarcomas are bulky, metastasize early, and are treated with neoadjuvant chemotherapy followed by resection.
• Left heart sarcomas are more circumscribed, metastasize later, and are often treated with surgery first.
• Pulmonary artery sarcomas are confined to the pulmonary artery, treated with resection, and may benefit from adjuvant radiation therapy.

Conclusions:

• Surgery provides the best local control for cardiac sarcomas, but distant metastases remain a challenge.
• Cardiac autotransplantation is a viable option for specific left heart sarcomas.
• Improved systemic therapies are essential for enhancing long-term survival in cardiac sarcoma patients.